The FY19 Defense Appropriation provides $130 million to the Department of Defense Breast Cancer Research Program to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public.
FY19 BCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.
Applications submitted to the FY19 BCRP must address one or more of the following overarching challenges:
Prevent breast cancer (primary prevention)
Identify determinants of breast cancer initiation, risk, or susceptibility
Distinguish deadly from non-deadly breast cancers
Conquer the problems of overdiagnosis and overtreatment
Identify what drives breast cancer growth; determine how to stop it
Identify why some breast cancers become metastatic
Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence
Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
Eliminate the mortality associated with metastatic breast cancer
